Keros Therapeutics, Inc.
KROS
$11.58
$0.110.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.51% | 30.75% | -8.27% | 33.61% | 15.02% |
| Total Receivables | 131.72% | 42.97% | -24.35% | 62.97% | 21.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.10% | -16.04% | 81.18% | -4.46% | -35.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.47% | -24.75% | 30.75% | 29.23% | 2.26% |
| Total Current Assets | 6.67% | 27.58% | -6.57% | 33.35% | 14.08% |
|
|
|||||
| Total Current Assets | 6.67% | 27.58% | -6.57% | 33.35% | 14.08% |
| Net Property, Plant & Equipment | -2.90% | 27.71% | -2.51% | -0.20% | 2.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.45% | -9.83% | 3.16% | 0.00% | 17.16% |
| Total Assets | 6.32% | 27.31% | -6.34% | 31.29% | 13.42% |
|
|
|||||
| Total Accounts Payable | -7.61% | -23.78% | 31.07% | -8.51% | 40.94% |
| Total Accrued Expenses | -6.24% | 65.92% | 11.17% | -31.45% | 46.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.52% | 69.43% | 4.38% | 4.48% | 64.48% |
| Total Finance Division Other Current Liabilities | 17.51% | -24.03% | -45.50% | 28.57% | 53.58% |
| Total Other Current Liabilities | 17.51% | -24.03% | -45.50% | 28.57% | 53.58% |
| Total Current Liabilities | -5.37% | 36.54% | 13.50% | -23.20% | 45.94% |
|
|
|||||
| Total Current Liabilities | -5.37% | 36.54% | 13.50% | -23.20% | 45.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.13% | 35.52% | -2.23% | -2.12% | -1.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -4.53% | 36.15% | 7.01% | -15.71% | 24.36% |
|
|
|||||
| Common Stock & APIC | 8.03% | 18.51% | 1.39% | 23.10% | 12.03% |
| Retained Earnings | -8.80% | -11.27% | -10.66% | -11.30% | -11.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.27% | 26.59% | -7.28% | 36.64% | 12.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.27% | 26.59% | -7.28% | 36.64% | 12.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.27% | 26.59% | -7.28% | 36.64% | 12.29% |
|
|
|||||
